Trial Profile
The Efficacy and Safety of Cleviprex in Ventriculostomy Patients Requiring IV Antihypertensive Therapy Investigator Initiated Trial.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 16 Aug 2019
Price :
$35
*
At a glance
- Drugs Clevidipine (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 12 Aug 2019 Planned End Date changed from 1 Jul 2013 to 31 Dec 2010.
- 12 Aug 2019 Planned primary completion date changed from 1 Jun 2013 to 31 Dec 2010.
- 20 Mar 2018 Status changed from recruiting to withdrawn prior to enrolment.